- Home
- MDAI vs ECOR Comparison
MDAI vs ECOR Comparison
Compare MDAI & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- ECOR
- Stock Information
- Founded
- MDAI 2013
- ECOR 2005
- Country
- MDAI United States
- ECOR United States
- Employees
- MDAI N/A
- ECOR N/A
- Industry
- MDAI Medical/Dental Instruments
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MDAI Health Care
- ECOR Health Care
- Exchange
- MDAI Nasdaq
- ECOR Nasdaq
- Market Cap
- MDAI 51.5M
- ECOR 50.1M
- IPO Year
- MDAI N/A
- ECOR 2018
- Fundamental
- Price
- MDAI $2.12
- ECOR $5.22
- Analyst Decision
- MDAI Strong Buy
- ECOR Strong Buy
- Analyst Count
- MDAI 2
- ECOR 2
- Target Price
- MDAI $4.75
- ECOR $25.50
- AVG Volume (30 Days)
- MDAI 455.5K
- ECOR 85.6K
- Earning Date
- MDAI 08-11-2025
- ECOR 08-06-2025
- Dividend Yield
- MDAI N/A
- ECOR N/A
- EPS Growth
- MDAI N/A
- ECOR N/A
- EPS
- MDAI N/A
- ECOR N/A
- Revenue
- MDAI $29,962,000.00
- ECOR $26,458,000.00
- Revenue This Year
- MDAI N/A
- ECOR $23.21
- Revenue Next Year
- MDAI $56.05
- ECOR $44.10
- P/E Ratio
- MDAI N/A
- ECOR N/A
- Revenue Growth
- MDAI 55.21
- ECOR 41.54
- 52 Week Low
- MDAI $0.82
- ECOR $4.47
- 52 Week High
- MDAI $3.25
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- MDAI 67.16
- ECOR 45.50
- Support Level
- MDAI $1.97
- ECOR $5.05
- Resistance Level
- MDAI $2.28
- ECOR $5.81
- Average True Range (ATR)
- MDAI 0.16
- ECOR 0.32
- MACD
- MDAI 0.01
- ECOR 0.05
- Stochastic Oscillator
- MDAI 82.81
- ECOR 39.84
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.